APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmacovigilance (PV) Outsourcing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmacovigilance (PV) Outsourcing Market Outlook and Growth Opportunities 2026

Report ID 174025270420 December 2025217 pages

Choose your research edition.

Industry ResearchPharmacovigilance (PV) Outsourcing Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacovigilance (PV) Outsourcing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pharmacovigilance (PV) Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacovigilance (PV) Outsourcing Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacovigilance (PV) Outsourcing Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Pharmacovigilance (PV) Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmacovigilance (PV) Outsourcing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmacovigilance (PV) Outsourcing market include Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation and iMED Global Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmacovigilance (PV) Outsourcing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacovigilance (PV) Outsourcing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacovigilance (PV) Outsourcing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmacovigilance (PV) Outsourcing market.

Pharmacovigilance (PV) Outsourcing Segment by Company

Accenture

C3i Solutions

Clintec

Covance

Deloitte Touche Tohmatsu Limited

ELC Group

Ergomed

iGATE Corporation

iMED Global Corporation

IQVIA

MarksMan Healthcare

Medpace Holdings

Oracle Corporation

Parexel

PharmInvent

PrimeVigilance

Pure Drug Safety

Sciformix

SIRO Clinpharm

Symogen

Novartis

Pharmacovigilance (PV) Outsourcing Segment by Type

Contract Research Organizations (CROs)

Business Process Outsourcing (BPOs)

Pharmacovigilance (PV) Outsourcing Segment by Application

Premarketing Clinical Trial

Post-marketing Clinical Practice

Other

Pharmacovigilance (PV) Outsourcing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pharmacovigilance (PV) Outsourcing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmacovigilance (PV) Outsourcing key companies, revenue, market share, and recent developments.

3. To split the Pharmacovigilance (PV) Outsourcing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmacovigilance (PV) Outsourcing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmacovigilance (PV) Outsourcing significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmacovigilance (PV) Outsourcing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance (PV) Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance (PV) Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance (PV) Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacovigilance (PV) Outsourcing industry.

Chapter 3: Detailed analysis of Pharmacovigilance (PV) Outsourcing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmacovigilance (PV) Outsourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmacovigilance (PV) Outsourcing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmacovigilance (PV) Outsourcing Industry Trends Table 2. Pharmacovigilance (PV) Outsourcing Industry Drivers Table 3. Pharmacovigilance (PV) Outsourcing Industry Opportunities and Challenges Table 4. Pharmacovigilance (PV) Outsourcing Industry Restraints Table 5. Global Pharmacovigilance (PV) Outsourcing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Company (2021-2026) Table 7. Global Pharmacovigilance (PV) Outsourcing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmacovigilance (PV) Outsourcing Key Company Manufacturing Base & Headquarters Table 9. Global Pharmacovigilance (PV) Outsourcing Company, Product Type & Application Table 10. Global Pharmacovigilance (PV) Outsourcing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmacovigilance (PV) Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Contract Research Organizations (CROs) Table 15. Significant Companies of Business Process Outsourcing (BPOs) Table 16. Global Pharmacovigilance (PV) Outsourcing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pharmacovigilance (PV) Outsourcing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pharmacovigilance (PV) Outsourcing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Type (2021-2026) Table 20. Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Premarketing Clinical Trial Table 22. Significant Companies of Post-marketing Clinical Practice Table 23. Significant Companies of Other Table 24. Global Pharmacovigilance (PV) Outsourcing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmacovigilance (PV) Outsourcing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pharmacovigilance (PV) Outsourcing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Application (2021-2026) Table 28. Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Application (2027-2032) Table 29. Global Pharmacovigilance (PV) Outsourcing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Region (2021-2026) Table 32. Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Region (2027-2032) Table 34. Global Pharmacovigilance (PV) Outsourcing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pharmacovigilance (PV) Outsourcing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pharmacovigilance (PV) Outsourcing Sales Value Market Share by Country (2021-2026) Table 37. Global Pharmacovigilance (PV) Outsourcing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pharmacovigilance (PV) Outsourcing Sales Value Market Share by Country (2027-2032) Table 39. Accenture Company Information Table 40. Accenture Business Overview Table 41. Accenture Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio Table 43. Accenture Recent Development Table 44. C3i Solutions Company Information Table 45. C3i Solutions Business Overview Table 46. C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio Table 48. C3i Solutions Recent Development Table 49. Clintec Company Information Table 50. Clintec Business Overview Table 51. Clintec Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio Table 53. Clintec Recent Development Table 54. Covance Company Information Table 55. Covance Business Overview Table 56. Covance Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Covance Pharmacovigilance (PV) Outsourcing Product Portfolio Table 58. Covance Recent Development Table 59. Deloitte Touche Tohmatsu Limited Company Information Table 60. Deloitte Touche Tohmatsu Limited Business Overview Table 61. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio Table 63. Deloitte Touche Tohmatsu Limited Recent Development Table 64. ELC Group Company Information Table 65. ELC Group Business Overview Table 66. ELC Group Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio Table 68. ELC Group Recent Development Table 69. Ergomed Company Information Table 70. Ergomed Business Overview Table 71. Ergomed Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio Table 73. Ergomed Recent Development Table 74. iGATE Corporation Company Information Table 75. iGATE Corporation Business Overview Table 76. iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 78. iGATE Corporation Recent Development Table 79. iMED Global Corporation Company Information Table 80. iMED Global Corporation Business Overview Table 81. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 83. iMED Global Corporation Recent Development Table 84. IQVIA Company Information Table 85. IQVIA Business Overview Table 86. IQVIA Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio Table 88. IQVIA Recent Development Table 89. MarksMan Healthcare Company Information Table 90. MarksMan Healthcare Business Overview Table 91. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio Table 93. MarksMan Healthcare Recent Development Table 94. Medpace Holdings Company Information Table 95. Medpace Holdings Business Overview Table 96. Medpace Holdings Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio Table 98. Medpace Holdings Recent Development Table 99. Oracle Corporation Company Information Table 100. Oracle Corporation Business Overview Table 101. Oracle Corporation Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 103. Oracle Corporation Recent Development Table 104. Parexel Company Information Table 105. Parexel Business Overview Table 106. Parexel Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio Table 108. Parexel Recent Development Table 109. PharmInvent Company Information Table 110. PharmInvent Business Overview Table 111. PharmInvent Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio Table 113. PharmInvent Recent Development Table 114. PrimeVigilance Company Information Table 115. PrimeVigilance Business Overview Table 116. PrimeVigilance Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio Table 118. PrimeVigilance Recent Development Table 119. Pure Drug Safety Company Information Table 120. Pure Drug Safety Business Overview Table 121. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio Table 123. Pure Drug Safety Recent Development Table 124. Sciformix Company Information Table 125. Sciformix Business Overview Table 126. Sciformix Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio Table 128. Sciformix Recent Development Table 129. SIRO Clinpharm Company Information Table 130. SIRO Clinpharm Business Overview Table 131. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio Table 133. SIRO Clinpharm Recent Development Table 134. Symogen Company Information Table 135. Symogen Business Overview Table 136. Symogen Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio Table 138. Symogen Recent Development Table 139. Novartis Company Information Table 140. Novartis Business Overview Table 141. Novartis Pharmacovigilance (PV) Outsourcing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio Table 143. Novartis Recent Development Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Pharmacovigilance (PV) Outsourcing Product Image Figure 2. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmacovigilance (PV) Outsourcing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Contract Research Organizations (CROs) Image Figure 8. Business Process Outsourcing (BPOs) Image Figure 9. Global Pharmacovigilance (PV) Outsourcing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pharmacovigilance (PV) Outsourcing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Type (2021-2032) Figure 12. Premarketing Clinical Trial Image Figure 13. Post-marketing Clinical Practice Image Figure 14. Other Image Figure 15. Global Pharmacovigilance (PV) Outsourcing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pharmacovigilance (PV) Outsourcing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Application (2021-2032) Figure 18. Global Pharmacovigilance (PV) Outsourcing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pharmacovigilance (PV) Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pharmacovigilance (PV) Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pharmacovigilance (PV) Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pharmacovigilance (PV) Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pharmacovigilance (PV) Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPOs)
Applications
  • Premarketing Clinical Trial
  • Post-marketing Clinical Practice
  • Other
Companies covered
  • Accenture
  • C3i Solutions
  • Clintec
  • Covance
  • Deloitte Touche Tohmatsu Limited
  • ELC Group
  • Ergomed
  • iGATE Corporation
  • iMED Global Corporation
  • IQVIA
  • MarksMan Healthcare
  • Medpace Holdings
  • Oracle Corporation
  • Parexel
  • PharmInvent
  • PrimeVigilance
  • Pure Drug Safety
  • Sciformix
  • SIRO Clinpharm
  • Symogen
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmacovigilance (PV) Outsourcing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmacovigilance (PV) Outsourcing Market Dynamics
  1. 2.1 Pharmacovigilance (PV) Outsourcing Industry Trends
  2. 2.2 Pharmacovigilance (PV) Outsourcing Industry Drivers
  3. 2.3 Pharmacovigilance (PV) Outsourcing Industry Opportunities and Challenges
  4. 2.4 Pharmacovigilance (PV) Outsourcing Industry Restraints
3 Pharmacovigilance (PV) Outsourcing Market by Company
  1. 3.1 Global Pharmacovigilance (PV) Outsourcing Company Revenue Ranking in 2025
  2. 3.2 Global Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2026)
  3. 3.3 Global Pharmacovigilance (PV) Outsourcing Company Ranking (2024-2026)
  4. 3.4 Global Pharmacovigilance (PV) Outsourcing Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmacovigilance (PV) Outsourcing Company Product Type and Application
  6. 3.6 Global Pharmacovigilance (PV) Outsourcing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmacovigilance (PV) Outsourcing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmacovigilance (PV) Outsourcing Market by Type
  1. 4.1 Pharmacovigilance (PV) Outsourcing Type Introduction
  2. 4.1.1 Contract Research Organizations (CROs)
  3. 4.1.2 Business Process Outsourcing (BPOs)
  4. 4.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Type
  5. 4.2.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Type (2021-2032)
5 Pharmacovigilance (PV) Outsourcing Market by Application
  1. 5.1 Pharmacovigilance (PV) Outsourcing Application Introduction
  2. 5.1.1 Premarketing Clinical Trial
  3. 5.1.2 Post-marketing Clinical Practice
  4. 5.1.3 Other
  5. 5.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Application
  6. 5.2.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmacovigilance (PV) Outsourcing Sales Value Share by Application (2021-2032)
6 Pharmacovigilance (PV) Outsourcing Regional Value Analysis
  1. 6.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032)
  7. 6.3.2 North America Pharmacovigilance (PV) Outsourcing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmacovigilance (PV) Outsourcing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032)
  16. 6.6.2 South America Pharmacovigilance (PV) Outsourcing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Sales Value Share by Country, 2025 VS 2032
7 Pharmacovigilance (PV) Outsourcing Country-level Value Analysis
  1. 7.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmacovigilance (PV) Outsourcing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmacovigilance (PV) Outsourcing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmacovigilance (PV) Outsourcing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Accenture
  2. 8.1.1 Accenture Company Information
  3. 8.1.2 Accenture Business Overview
  4. 8.1.3 Accenture Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio
  6. 8.1.5 Accenture Recent Developments
  7. 8.2 C3i Solutions
  8. 8.2.1 C3i Solutions Company Information
  9. 8.2.2 C3i Solutions Business Overview
  10. 8.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio
  12. 8.2.5 C3i Solutions Recent Developments
  13. 8.3 Clintec
  14. 8.3.1 Clintec Company Information
  15. 8.3.2 Clintec Business Overview
  16. 8.3.3 Clintec Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio
  18. 8.3.5 Clintec Recent Developments
  19. 8.4 Covance
  20. 8.4.1 Covance Company Information
  21. 8.4.2 Covance Business Overview
  22. 8.4.3 Covance Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Covance Pharmacovigilance (PV) Outsourcing Product Portfolio
  24. 8.4.5 Covance Recent Developments
  25. 8.5 Deloitte Touche Tohmatsu Limited
  26. 8.5.1 Deloitte Touche Tohmatsu Limited Company Information
  27. 8.5.2 Deloitte Touche Tohmatsu Limited Business Overview
  28. 8.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio
  30. 8.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
  31. 8.6 ELC Group
  32. 8.6.1 ELC Group Company Information
  33. 8.6.2 ELC Group Business Overview
  34. 8.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio
  36. 8.6.5 ELC Group Recent Developments
  37. 8.7 Ergomed
  38. 8.7.1 Ergomed Company Information
  39. 8.7.2 Ergomed Business Overview
  40. 8.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio
  42. 8.7.5 Ergomed Recent Developments
  43. 8.8 iGATE Corporation
  44. 8.8.1 iGATE Corporation Company Information
  45. 8.8.2 iGATE Corporation Business Overview
  46. 8.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  48. 8.8.5 iGATE Corporation Recent Developments
  49. 8.9 iMED Global Corporation
  50. 8.9.1 iMED Global Corporation Company Information
  51. 8.9.2 iMED Global Corporation Business Overview
  52. 8.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  54. 8.9.5 iMED Global Corporation Recent Developments
  55. 8.10 IQVIA
  56. 8.10.1 IQVIA Company Information
  57. 8.10.2 IQVIA Business Overview
  58. 8.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio
  60. 8.10.5 IQVIA Recent Developments
  61. 8.11 MarksMan Healthcare
  62. 8.11.1 MarksMan Healthcare Company Information
  63. 8.11.2 MarksMan Healthcare Business Overview
  64. 8.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio
  66. 8.11.5 MarksMan Healthcare Recent Developments
  67. 8.12 Medpace Holdings
  68. 8.12.1 Medpace Holdings Company Information
  69. 8.12.2 Medpace Holdings Business Overview
  70. 8.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio
  72. 8.12.5 Medpace Holdings Recent Developments
  73. 8.13 Oracle Corporation
  74. 8.13.1 Oracle Corporation Company Information
  75. 8.13.2 Oracle Corporation Business Overview
  76. 8.13.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  78. 8.13.5 Oracle Corporation Recent Developments
  79. 8.14 Parexel
  80. 8.14.1 Parexel Company Information
  81. 8.14.2 Parexel Business Overview
  82. 8.14.3 Parexel Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio
  84. 8.14.5 Parexel Recent Developments
  85. 8.15 PharmInvent
  86. 8.15.1 PharmInvent Company Information
  87. 8.15.2 PharmInvent Business Overview
  88. 8.15.3 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio
  90. 8.15.5 PharmInvent Recent Developments
  91. 8.16 PrimeVigilance
  92. 8.16.1 PrimeVigilance Company Information
  93. 8.16.2 PrimeVigilance Business Overview
  94. 8.16.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio
  96. 8.16.5 PrimeVigilance Recent Developments
  97. 8.17 Pure Drug Safety
  98. 8.17.1 Pure Drug Safety Company Information
  99. 8.17.2 Pure Drug Safety Business Overview
  100. 8.17.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio
  102. 8.17.5 Pure Drug Safety Recent Developments
  103. 8.18 Sciformix
  104. 8.18.1 Sciformix Company Information
  105. 8.18.2 Sciformix Business Overview
  106. 8.18.3 Sciformix Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio
  108. 8.18.5 Sciformix Recent Developments
  109. 8.19 SIRO Clinpharm
  110. 8.19.1 SIRO Clinpharm Company Information
  111. 8.19.2 SIRO Clinpharm Business Overview
  112. 8.19.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio
  114. 8.19.5 SIRO Clinpharm Recent Developments
  115. 8.20 Symogen
  116. 8.20.1 Symogen Company Information
  117. 8.20.2 Symogen Business Overview
  118. 8.20.3 Symogen Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio
  120. 8.20.5 Symogen Recent Developments
  121. 8.21 Novartis
  122. 8.21.1 Novartis Company Information
  123. 8.21.2 Novartis Business Overview
  124. 8.21.3 Novartis Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio
  126. 8.21.5 Novartis Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst